This inventor holds 1 USPTO granted patent. Top assignee: Amolyt Pharma. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Michel Julien: Innovator in Bone Disorder Treatments
Introduction
Michel Julien is a prominent inventor based in Lyon, France. He has made significant contributions to the field of medical technology, particularly in the treatment of bone disorders. His innovative work has led to the development of valuable patents that aim to improve patient outcomes.
Latest Patents
Michel Julien holds a patent for "Compounds, compositions and uses thereof for improvement of bone disorders." This technology relates to peptides of IGFBP-2 that may be utilized to enhance the treatment of bone disorders. The patent outlines methods for preventing or treating these conditions, as well as the compositions necessary for such uses.
Career Highlights
Julien is associated with Amolyt Pharma, a company dedicated to advancing therapies for patients with rare diseases. His work at Amolyt Pharma has positioned him as a key player in the development of innovative solutions for bone health.
Collaborations
Throughout his career, Michel Julien has collaborated with notable professionals in the field, including Thierry Abribat and David Clemmons. These partnerships have fostered a collaborative environment that enhances the research and development of new treatments.
Conclusion
Michel Julien's contributions to the field of bone disorder treatments through his innovative patents and collaborations highlight his commitment to improving healthcare. His work continues to pave the way for advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile